How Can iPSCs Contribute to Reducing Animal Testing?
iPSCs have the potential to significantly reduce the reliance on animal testing in toxicology. By providing a human-relevant model, iPSCs can serve as an alternative to animal models for initial toxicity screening. The development of organ-on-a-chip technologies using iPSC-derived cells further enhances their application by mimicking human organ functions. This approach not only improves the predictive power of toxicology assessments but also aligns with ethical considerations by minimizing the use of animals in research.
